Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience

Ovarian cancer is the most lethal gynecological cancer, and despite years of research, with the exception of a BRCA mutation driving the use of PARP inhibitors, no new prognostic/predictive biomarkers are clinically available. Improvement in biomarker selection and validation may derive from the sys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Califano, Daniela, Russo, Daniela, Scognamiglio, Giosuè, Losito, Nunzia Simona, Spina, Anna, Bello, Anna Maria, Capiluongo, Anna, Galdiero, Francesca, De Cecio, Rossella, Bevilacqua, Simona, Gargiulo, Piera, Marchesi, Edoardo, Canevari, Silvana, Perrone, Francesco, Daniele, Gennaro, De Cecco, Loris, Mezzanzanica, Delia, Pignata, Sandro
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226822/
https://ncbi.nlm.nih.gov/pubmed/32272732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9040903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados